As of 2024-12-12, the EV/EBITDA ratio of Pharmasimple SA (ALPHS.PA) is -5.39. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ALPHS.PA's latest enterprise value is 4.31 mil EUR. ALPHS.PA's TTM EBITDA according to its financial statements is -0.80 mil EUR. Dividing these 2 quantities gives us the above ALPHS.PA EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | EV/EBITDA |